ABSTRACT
The contribution of blockade of adenosine A 1 and A 2A receptor to the psychostimulant effects of caffeine is still a matter of debate. When analyzing motor activity in rats, acutely administered caffeine shows a profile of a nonselective adenosine receptor antagonist, although with preferential A 1 receptor antagonism. On the other hand, tolerance to the effects of A 1 receptor blockade seems to be mostly responsible for the tolerance to the motor-activating effects of caffeine, while the residual motor-activating effects of caffeine in tolerant individuals seem to involve A 2A receptor blockade. These behavioral studies correlate with in vivo microdialysis experiments that suggest that A 1 receptor-mediated modulation of striatal glutamate release is involved in the psychostimulant effects of caffeine.
Experiments in transfected cells demonstrate the ability of A 1 receptors to heteromerize with A 2A receptors and the A 1 -A 2A receptor heteromer can be biochemically identified in the striatum, in striatal glutamatergic terminals. The striatal A 1 -A 2A receptor heteromer provides a "concentrationdependent switch" mechanism by which low and high concentrations of synaptic adenosine produce the opposite effects on glutamate release. The analysis of the function of A 1 -A 2A receptor heteromers during chronic treatment with caffeine gives new clues about the well-known phenomenon of tolerance to the psychostimulant effects of caffeine.
TARGETING ADENOSINE RECEPTORS
Caffeine is the most consumed psychoactive drug in the world (1). As a psychostimulant, it produces reinforcing effects, motor-activating effects and arousal (1). It was already proposed more than twenty years ago that the psychostimulant effects of caffeine and related methylxanthines, as well as their multiple non-central effects (including lipolysis in adipose tissue, increased renal blood flow, release of catecholamines and increased heart rate) were mainly due to antagonism of endogenous adenosine (2-4). Among the four cloned adenosine receptors (A 1 , A 2A , A 2B and A 3 receptors), A 1 and A 2A receptors are the ones predominantly expressed in the brain. Caffeine is a non-selective adenosine receptor antagonist, with reported similar in vitro affinities for A 1 , A 2A and A 2B receptors and with lower affinity for A 3 receptors (5, 6) . Physiological extracellular levels of adenosine can be sufficient to occupy and, therefore, stimulate A 1 and A 2A receptors. On the other hand, A 2B receptors have a lower affinity for adenosine and they are only activated by high pathological extracellular levels of adenosine (5) . Thus, A 1 and A 2A receptors seem to be the preferential targets for caffeine in the brain, although their involvement in the psychostimulant effects of caffeine still remains controversial. A 1 receptors are widely expressed in the brain, while A 2A receptors are highly concentrated in the striatum (5, 7). The striatal localization of both receptors can underlie the reinforcing and motor activating effects of caffeine, while A 1 receptors localized in the brainstem and basal forebrain and A 2A receptors localized in the hypothalamus have been suggested to be involved in caffeine-induced arousal (see below).
Based upon a correlation between potencies of a series of methylxanthines in stimulating locomotor activity of mice and in competing at adenosine receptors labeled with a tritiated A 1 receptor agonist, Snyder et al. (8) initially suggested that the motor stimulant effects of methylxanthines involve the blockade of A 1 receptors. At that time little was known about the role of A 2A receptors, especially because of the lack of specific A 2A receptor ligands. Nevertheless, later on, studies in mice and monkeys suggested that there was a better correlation between the locomotor depressant effects of several adenosine receptor agonists and their ability to bind to A 2A receptors (9, 10) . Also, there seemed to be a better correlation between the ability of several methylxanthines to produce motor stimulation in monkeys (increase in response rate in schedule-controlled behavior) and their ability to bind A 2A receptors (11) . It was then suggested that blockade of A 2A receptors was mainly responsible for the motor stimulating effects of caffeine (11) . This hypothesis was strengthened by more recent findings demonstrating the ability of A 2A receptor antagonists and the inability of some A 1 receptor antagonists to reproduce some biochemical and behavioral effects of caffeine (12, 13) . Furthermore, caffeine was found to be ineffective at producing motor activation in A 2A receptor knockout mice (14) . Also, some results obtained in A 2A receptor knockout and wild-type mice even suggested that A 1 receptor antagonism induces motor depression, which could be responsible for the motor depressant effect observed with high doses of caffeine (13) . However, these results were at odds with the results of other research groups which strongly suggested that A 1 receptor antagonists induce motor activation and that they potentiate the motor activating effects of A 2A receptor antagonists (15, 16) .
We then performed a systematic study that compared the counteraction of the motor depressant effects of selective A 1 and A 2A receptor agonists by caffeine and selective A 1 and A 2A receptor antagonists in rats (17) . The A 1 receptor antagonist CPT and the A 2A receptor antagonist MSX-3 produced motor activation at the same doses that selectively counteracted the motor depression induced by the A 1 receptor agonist CPA and the A 2A receptor agonist CGS 21680, respectively. Caffeine, at the doses that produced motor activation, was found to have a profile more similar to CPT than to MSX-3, since it more potently counteracted the motor depressant effects of CPA than of CGS 21680. Thus, caffeine showed a profile of a nonselective adenosine receptor antagonist, although with preferential A 1 receptor antagonism (17) . A recent detailed behavioral analysis further supported the predominant role of A 1 receptors in the motor-activating effects of acutely administered caffeine. Thus, factor analysis (a statistical procedure that allows inter-correlated variables to be condensed into fewer dimensions, called factors) depicted a very similar three-dimensional profile for caffeine and the A 1 receptor antagonist CPT, which was different from a two-dimensional profile of the A 2A receptor antagonist MSX-3 (18) . Recent experiments using genetic inactivation of A 1 , A 2A or both receptors have revisited the previously hypothesized involvement of A 1 receptors in the depressant motor activation induced by high doses of caffeine (13) . The results of those experiments support that A 1 receptor contributes to the stimulatory but not the inhibitory motor activating effects of caffeine (19) .
Other results supporting the role of A 1 receptors in the psychostimulant effects of caffeine come from drug discrimination studies. Drug discrimination techniques have been used to classify and characterize the effects of abused drugs, including psychostimulants, since trained animals can be used to determine whether test substances are identified as being similar to the drug used for training (same pharmacological class) (20) . Thus, in drug discrimination experiments, caffeine can substitute for other psychostimulants and the other way around (6, 21, 22) . In rats trained to discriminate an injection of a motoractivating dose of caffeine from saline, CPT and the nonselective adenosine antagonist DMPX, but not MSX-3, produced significant caffeine-like discriminative effects. Furthermore, the A 1 receptor agonist CPA, but not the A 2A receptor agonist CGS 21680, dose-dependently reduced caffeine's discriminative effects (6) . Therefore, these results strongly support a key involvement of A 1 receptors in the acute psychostimulant effects of caffeine (6) . Chronic exposure to caffeine differentially modifies its motor effects dependent on A 1 and A 2A receptor blockade. Thus, chronic exposure to caffeine in the drinking water results in partial tolerance to the motor effects of an additional acute administration of caffeine and total cross-tolerance to the motor effects of CPT, but not of MSX-3 (17) . This suggests that tolerance to the effects of A 1 receptor blockade is mostly responsible for the tolerance to the motor-activating effects of caffeine and that the residual motor-activating effects of caffeine in tolerant individuals might be mostly because of A 2A receptor blockade. These results agree with other experimental findings showing a lack of tolerance of the motor activating effects of A 2A receptor antagonists with their repeated administration (25) . Similarly, in unilateral 6-OHdopamine-lesioned rats, chronic treatment with caffeine or repeated administration of an A 2A receptor antagonist was not associated with tolerance to the A 2A receptor antagonist-induced potentiation of turning behavior produced by dopamine receptor agonists (26, 27) .
Although experiments with place-and tastepreference paradigms have demonstrated the reinforcing effects of caffeine (28) (29) (30) , the lack of selectivity of the adenosine receptor ligands used in those experiments does not allow the establishment of a clear role of A 1 or A 2A receptors in the reinforcing effects of caffeine. In relation to the arousal-enhancing effects of caffeine, adenosine has been demonstrated to be a potent endogenous sleepinducing substance, based on experimental evidence obtained from a variety of pharmacological and behavioral studies. For example, adenosine and its stable analogues are known to induce sleep when administered to rats, cats, and other experimental animals (31) . The concentration of extracellular adenosine increases in the cortex and basal forebrain during sleep deprivation of cats and decreases during the recovery period after sleep deprivation (32) . Because energy restoration is one of the functions of sleep, adenosine is proposed to be produced as a terminal product of energy metabolism and to act as a homeostatic regulator of energy in the brain during sleep. The well-known arousal-enhancing properties of caffeine depend on its ability to antagonize the sleep-promoting effects of adenosine (reviewed in refs. 33 and 34). Although previous results suggested that A 1 receptors are involved in sleep regulation by inhibiting ascending cholinergic neurons of the basal forebrain (31, 32) , more recent studies, which include experiments with A 2A and A 1 receptor knockout mice, indicate that A 2A receptors (most probably localized in the ventrolateral preoptic area of the hypothalamus) play a crucial role in the sleep-promoting effects of adenosine and the arousal-enhancing effects of caffeine (33, 34) .
TARGETING THE STRIATAL SPINE MODULE
As is the case for other psychostimulants, the motor and discriminative stimulus effects of caffeine are dopamine dependent. Caffeine's discriminative stimulus effects are counteracted by dopamine D 1 and D 2 receptor antagonists (at doses that do not decrease the rate of responding) (6, 35) . Caffeine-induced motor activation can be counteracted by drugs that either block dopamine receptors or produce dopamine depletion (reviewed in refs. 36 and 37). Finally, although not directly demonstrated, it is most likely that the reinforcing effects of caffeine are also dopaminedependent, since dopamine is crucial in most instances of positive reinforcement. Thus, rewarding stimuli fail to serve as effective reinforcers in dopamine-compromised animals (38) .
The dopamine dependency of the psychostimulant effects of caffeine can be explained by the existence of important interactions between adenosine and dopamine in the brain and the main locus where these interactions seem to be particularly relevant is the "striatal spine module". The GABAergic striatal efferent neuron constitutes more than 90% of the striatal neuronal population (39) . Also called medium sized spiny neuron, since it contains a high density of dendritic spines, the GABAergic striatal efferent neuron receives two main inputs, glutamatergic afferents from cortical, limbic and thalamic areas and dopaminergic afferents from the mesencephalon, either the substantia nigra pars reticulata or the ventral tegmental area (39) . Both inputs converge in the dendritic spine. The glutamatergic terminal makes synaptic contact with the head of the dendritic spine, while the dopaminergic terminal makes synaptic contact preferentially with the neck of the dendritic spine (39) . The dendritic spine, the dopaminergic and glutamatergic terminals and astroglial processes that wrap the glutamatergic synapse constitute the most common striatal local module, which we recently called striatal spine module (40) . This arrangement allows dopamine neurotransmission to regulate glutamatergic neurotransmission. But glutamate is not only released synaptically to stimulate intrasynaptic glutamatergic receptors, mostly ionotropic receptors. There is also volume transmission of glutamate, which can spillover the synaptic cleft and by an amplificatory mechanism that involves the astroglia, stimulates extrasynaptic receptors localized both pre-and postsynaptically at the glutamatergic and dopaminergic synapses. These extrasynaptic glutamatergic receptors are metabotropic or ionotropic glutamate receptors which modulate glutamate and dopamine release. Similarly, dopamine is not only released synaptically but it can also spillover or be released by asynaptic varicosities and stimulate extrasynaptic receptors that are located both pre-and post-synaptically at both glutamatergic and dopaminergic synapses (reviewed in ref. 40 ).
In the striatal spine module adenosine is a key modulator of dopaminergic and glutamatergic neurotransmission. Until recently it was believed that the main source of extracellular adenosine was a paracrine-like formation. Extracellular adenosine would come mostly from intracellular adenosine, the concentration of which depends upon the breakdown and synthesis of ATP, which is metabolized to AMP and, then, by means of 5'nucleotidases it is converted to adenosine, which can be transported to the extracelular space by means of equilibrative transporters (41) . However, recent studies suggest that astroglia play a fundamental role in the formation of extracellular adenosine which affects synaptic transmission. Astrocytes express glutamate receptors (mostly metabotropic) and ATP receptors which, when activated, induce astrocytes to release glutamate and ATP (42, 43) . Astroglial-released ATP can be converted to adenosine in the extracellular space by means of ectonucleotidases (44) . Finally, there is an increasing amount of data suggesting the existence of a neurotransmitter-like formation of adenosine, a synaptic pool of adenosine. In this case, adenosine would come from ATP co-released with glutamate, which is metabolized to adenosine by means of ectonucleotidases (41) .
What is the localization of adenosine receptors in the striatal spine module? There are two subtypes of GABAergic striatal efferent neurons, the striatopallidal neuron, also called enkephalinergic neuron, which expresses the peptide enkephalin and dopamine and We first postulated that these postsynaptic A 1 and A 2A receptors, forming heteromers with D 1 and D 2 receptors, respectively, could provide a framework for adenosine-dopamine interactions in the brain and that they could be mostly responsible for the motor and reinforcing effects of caffeine (36, 45) . However, we found evidence for the existence of presynaptic effects of caffeine that could not be explained by its effects on the A 2A -D 2 and A 1 -D 1 receptor heteromers. As shown by in vivo microdialysis, systemic administration of caffeine produced a significant increase in the extracellular concentrations of dopamine and glutamate in the ventral striatum, particularly in the most medial part, the medial shell of the nucleus accumbens (59, 60) . The same effect was observed with the systemic administration of CPT, while MSX-3 produced the opposite effect, a small but significant decrease in the extracellular concentration of dopamine and glutamate in the nucleus accumbens (61) . Furthermore, chronic administration of caffeine in the drinking water completely counteracted the effects of caffeine or CPT on dopamine and glutamate, while the effect of MSX-3 was not modified (61) . Thus, these biochemical changes correlated with our previous studies on motor activity. Dopamine release in the medial striatal compartments seems to be involved in invigoration of approach and in some aspects of incentive learning (for recent review, see ref (62)). In relation to psychostimulants, dopamine release in the very medial striatal compartments seems to be involved in both their locomotor-activating and reinforcing effects (62) . Therefore, presynaptic mechanisms (striatal dopamine release) are probably involved in the motor, reinforcing and maybe discriminative stimulus effects of caffeine. In fact, the development of tolerance to the dopamine-releasing effects of caffeine in the nucleus accumbens could be one of the factors that explain its weaker reinforcing properties as compared with other psychostimulants.
THE STRIATAL ADENOSINE A 1 -A 2A RECEPTOR HETEROMER
The effects of systemic administration of caffeine and CPT on striatal dopamine and glutamate were also replicated by local perfusion of these compounds in the nucleus accumbens (63) . Furthermore, local perfusion of the A 2A receptor agonist CGS 21680 also produced an increase in the extracellular concentrations of dopamine and glutamate in the nucleus accumbens (63) . The effects of A 1 receptor blockade or A 2A receptor stimulation were antagonized by blocking NMDA receptors, suggesting that the changes in dopamine release are secondary to glutamate release and stimulation of NMDA receptors localized in dopaminergic terminals (63) . The results indicated that A 1 and A 2A receptors exert an important control of striatal glutamate release and, therefore, they would probably be co-localized in glutamatergic terminals. Nevertheless, it must be pointed out that there is also evidence for a glutamate-independent A 1 receptor-mediated modulation of striatal dopamine release, which depends on the existence of A 1 receptors in a fraction of striatal dopaminergic terminals (60) (Figure 2) The A 1 -A 2A receptor co-localization on striatal glutamatergic terminals was demonstrated by electron microscopy experiments, labeling A1 receptors with immunoperoxidase and A2A receptors with immunogold. Interestingly, presynaptic A1 and A2A receptors were mostly found inside the synapse (24) (Figure 2) . Thus, they are in a position to modulate adenosine generated by synaptically released ATP.
Furthermore, immunocytochemical experiments in striatal nerve terminal preparations showed that the majority of glutamatergic nerve terminals contain both A 1 and A 2A receptors (24) . Functional studies were then performed in striatal nerve terminals in order to understand the significance of having two receptor subtypes (A 1 and A 2A receptors) of the same neurotransmitter (adenosine) with opposite functional effects (inhibition and stimulation of neurotransmitter release) co-localized in the same nerve terminals. In striatal nerve terminal preparations, stimulation of the A 1 receptor, with the A 1 receptor agonist CPA, decreases and stimulation of A 2A receptors with CGS 21680 potentiates potassium-induced glutamate release (24) . Importantly, when both A 1 and A 2A receptors are stimulated, the response is not a counteractive effect, but the same than results from A 2A receptor stimulation, i.e., a potentiation of glutamate release (24) . Furthermore, in the same kind of preparation, low concentrations of adenosine inhibit while high concentrations stimulate glutamate release (24) . This would agree with a higher affinity for adenosine of the A 1 compared to the A 2A receptor (23) for the same neurotransmitter) and demonstrates that neurotransmitter heteromers composed of isoreceptors with different affinities for their endogenous neurotransmitter and different signaling pathways can act as concentrationdependent processors that exert a fine-tuned modulation of neurotransmission. In this case we have a neurotransmitter released or formed in the synaptic space which acts on synaptically or perisynaptically located heteromers. A weak input results in the stimulation of the receptor with the highest affinity for the neurotransmitter, while a strong input results in the additional stimulation of the other receptor, with the establishment of the intermolecular cross-talk between both receptors an a different neuronal response.
Finally, we also analyzed if chronic treatment with caffeine alters the function of the striatal A 1 -A 2A receptor heteromer. In fact, a remarkable finding was an increased intermolecular cross-talk in the A 1 -A 2A receptor, with a significant increase in the potency of A 2A receptor agonist-mediated inhibition of A 1 receptor agonist binding (24) . The affinity of the striatal A 2A receptor for caffeine was also reduced (24) . One additional variable has to be taken into account when analyzing the effects of chronic caffeine administration, which is an increase in the plasma and extracellular levels of adenosine. Thus, Conlay et al. (64) demonstrated that the same treatment with caffeine that we used in our biochemical experiments (1 mg/ml in the drinking water for 14 days) leads to a 10-fold increase in plasma adenosine levels (64) . The following model can explain the above mentioned experimental findings ( Figure  3 ): In naïve rats, due to the relatively low levels of endogenous adenosine and the higher affinity of A 1 receptor for the agonist, there is a preferential A 1 receptormediated signaling in the A 1 -A 2A receptor heteromer. Under these conditions, the administration of caffeine induces a preferential blockade of A 1 receptor function in the A 1 -A 2A receptor heteromer. In rats chronically treated with caffeine, the higher adenosine levels and low affinity of the A 2A receptor for caffeine compared to the A 1 receptor allows endogenous adenosine to stimulate A 2A receptors even in the presence of caffeine, which does not reach enough concentration to compete with adenosine for binding A 2A receptors. The A 1 receptor signaling, on the other hand, is turned down because of its blockade by caffeine and because of the strong A 2A receptor-mediated inhibition of A 1 receptor agonist binding. Under these conditions an additional administration of caffeine produces a blockade of the residual A 2A receptor signaling (Figure 3 ).
CONCLUSIONS
In previous reports, A 2A -D 2 receptor heteromers localized in striatal enkephalinergic neurons and A 1 -D 1 receptor heteromers localized in striatal dynorphinergic neurons were suggested to be main targets responsible for the pshychostimulant effects of caffeine (36, 45, 46) . In fact, striatal enkephalinergic neurons contain the highest density of A 2A receptors in the brain (7) and their blockade seems to be mainly responsible for the antiparkinsonian effects of A 2A receptor antagonists (7, 65, 66) . Nevertheless, the above reviewed experimental work strongly suggests that the A 1 -A 2A receptor heteromer localized in striatal glutamatergic nerve terminals plays an important role in the motoractivating and, also possibly, in the reinforcing and discriminative-stimulus effects of caffeine. Furthermore, the analysis of the function of A 1 -A 2A receptor heteromers during chronic treatment with caffeine allows a better understanding of the well-known phenomenon of tolerance to the psychostimulant effects of caffeine.
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